- Home
- FSI vs HLVX Comparison
FSI vs HLVX Comparison
Compare FSI & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSI
- HLVX
- Stock Information
- Founded
- FSI 1991
- HLVX 2020
- Country
- FSI Canada
- HLVX United States
- Employees
- FSI N/A
- HLVX N/A
- Industry
- FSI Recreational Games/Products/Toys
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- FSI Consumer Discretionary
- HLVX Health Care
- Exchange
- FSI Nasdaq
- HLVX Nasdaq
- Market Cap
- FSI 120.2M
- HLVX 104.3M
- IPO Year
- FSI 1999
- HLVX 2022
- Fundamental
- Price
- FSI $9.65
- HLVX $2.09
- Analyst Decision
- FSI
- HLVX Hold
- Analyst Count
- FSI 0
- HLVX 1
- Target Price
- FSI N/A
- HLVX $2.00
- AVG Volume (30 Days)
- FSI 107.2K
- HLVX 824.4K
- Earning Date
- FSI 11-13-2025
- HLVX 11-06-2025
- Dividend Yield
- FSI 1.03%
- HLVX N/A
- EPS Growth
- FSI 5.17
- HLVX N/A
- EPS
- FSI 0.23
- HLVX N/A
- Revenue
- FSI $37,322,073.00
- HLVX N/A
- Revenue This Year
- FSI $14.14
- HLVX N/A
- Revenue Next Year
- FSI $66.41
- HLVX N/A
- P/E Ratio
- FSI $42.12
- HLVX N/A
- Revenue Growth
- FSI N/A
- HLVX N/A
- 52 Week Low
- FSI $3.18
- HLVX $1.34
- 52 Week High
- FSI $11.48
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- FSI 61.89
- HLVX 51.68
- Support Level
- FSI $9.19
- HLVX $2.07
- Resistance Level
- FSI $9.86
- HLVX $2.11
- Average True Range (ATR)
- FSI 0.83
- HLVX 0.03
- MACD
- FSI -0.14
- HLVX -0.00
- Stochastic Oscillator
- FSI 50.61
- HLVX 33.33
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.